Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
53.4M
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
14M
-
Shares change
-
-1.55M
-
Total reported value, excl. options
-
$91.3M
-
Value change
-
-$10.1M
-
Put/Call ratio
-
0.94
-
Number of buys
-
13
-
Number of sells
-
-15
-
Price
-
$6.52
Significant Holders of scPharmaceuticals Inc. - Common Stock (SCPH) as of Q3 2022
43 filings reported holding SCPH - scPharmaceuticals Inc. - Common Stock as of Q3 2022.
scPharmaceuticals Inc. - Common Stock (SCPH) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14M shares
of 53.4M outstanding shares and own 26.28% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (4.8M shares), 5AM Venture Management, LLC (3.33M shares), ARMISTICE CAPITAL, LLC (2.49M shares), AIGH Capital Management LLC (757K shares), VANGUARD GROUP INC (617K shares), Ikarian Capital, LLC (479K shares), Worth Venture Partners, LLC (189K shares), RENAISSANCE TECHNOLOGIES LLC (180K shares), DIMENSIONAL FUND ADVISORS LP (139K shares), and BRIDGEWAY CAPITAL MANAGEMENT, LLC (132K shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.